Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study (Q24538955)

8

object named as

Deenan Pillay

0 references

Andrew N Phillips

7

object named as

Andrew Phillips

0 references

author name string

Patricia Cane

1

0 references

Ian Chrystie

2

0 references

David Dunn

3

0 references

Barry Evans

4

0 references

Anna Maria Geretti

5

0 references

Hannah Green

6

0 references

Kholoud Porter

9

0 references

Anton Pozniak

10

0 references

Erasmus Smit

12

0 references

Jonathan Weber

13

0 references

Mark Zuckerman

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

14

0 references

language of work or name

English

0 references

publication date

10 December 2005

0 references

published in

The BMJ

0 references

volume

331

0 references

issue

7529

0 references

page(s)

1368

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Update of the drug resistance mutations in HIV-1: 2004.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Time trends in primary HIV-1 drug resistance among recently infected persons

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Updated European recommendations for the clinical use of HIV drug resistance testing

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Development of a novel human immunodeficiency virus type 1 subtyping tool, Subtype Analyzer (STAR): analysis of subtype distribution in London

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Extensive antiretroviral therapy resistance in an HIV-infected Zimbabwean patient in the UK

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Antiretroviral-drug resistance among patients recently infected with HIV.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1309643

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

29 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16299012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. UK Register of HIV Seroconverters Steering Committee

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16299012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.38665.534595.55

1 reference

2797974

2797974

1 reference

1 reference

1 reference